UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~June~~August 1712, 2014

NEUROMAMA, LTD.

(Exact name of registrant as specified in charter)


Nevada	333-180750	98-0706304
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

Blvd. Benito Juarez Km 25.500, Quinta Del Mar, Int. Suite 28

Playas de Rosarito B.C, Mexico

(Address of principal executive offices)

c.p. 22710

(Zip Code)

+52 (664) 290-5048

Registrant’s telephone number

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

Item 45.0102. Departure ~~Changes~~of inDirectors ~~Registrant’s~~or ~~Certifying~~Certain ~~Accountant~~Officers; Election of Directors; Appointment of Certain Officers.

~~(a)~~ On ~~June~~August 1712, 2014, ~~Silberstein Ungar, PLLC CPAs (“Silberstein”), the principal accountant for~~ Neuromama, Ltd. (the "“Company"”) ~~resigned~~received asresignation ~~the~~notices ~~Company’s~~from ~~principal~~Alexander ~~accountant. The~~Vikoulov ~~Company’s~~as ~~Board~~Chief ofFinancial ~~Directors~~Officer ~~approved~~and ~~the~~Director ~~resignation~~ of ~~Silberstein on~~ the ~~same date~~Company. ~~None~~Mr. ofVikoulov ~~the~~no ~~reports~~longer ~~of Silberstein,~~holds onany ~~the~~positions Company's financial statements for either of the past two years or subsequent interim period contained an adverse opinion or disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope or accounting principles, except that the Company’s audited financial statements contained in its Form 10-K for the year ended January 31, 2013, filed with the ~~Commission on April 10, 2013, contained a going concern qualification in the~~ Company~~'s audited financial statements~~.

~~There~~Mr. ~~were~~Vikoulov’s noresignations ~~disagreements~~were ~~between~~not ~~the~~due ~~Company~~to ~~and~~any ~~Silberstein,~~disagreement ~~for~~with the ~~two~~Company ~~most recent fiscal years and any subsequent interim period through June 17, 2014 (date of resignation)~~ on any matter ofrelating ~~accounting~~to ~~principles~~its ~~or practices~~operations, ~~financial~~policies ~~statement disclosure,~~ or ~~auditing scope or procedure, which, if not resolved to the satisfaction of Silberstein, would have caused them to make reference to the subject matter of the disagreement in connection with its report~~practices.

~~SIGNATURES~~On August 12, 2014, the Company, and a majority of its shareholders by written consent, appointed Karapet Gevorgya, its current Treasurer and Secretary as its new Chief Financial Officer and as Director.

~~Pursuant~~Mr. toGevorgyan ~~the~~studied ~~requirements~~Computer ofAided ~~the~~Manufacturing ~~Securities~~in ~~Exchange~~Cybernetics ~~Act~~at ~~of 1934,~~ the ~~Registrant~~Yerevan ~~has~~Polytechnic ~~duly~~Institute. From ~~caused~~2005 ~~this report~~ to bepresent, ~~signed~~Mr. onGevorgyan ~~its~~has ~~behalf~~worked byat ~~the~~SNG/USA ~~undersigned~~Event ~~hereunto~~Production, ~~duly~~a ~~authorized~~private company.

	NEUROMAMA, LTD.
Date: July 3, 2014	By:	/s/ Igor Weselovsky
		Igor Weselovsky, President, Chief Executive Officer & Director

Mr. Gevorgyan will serve as our officer until his duly elected successor is appointed or he resigns. There are no arrangements or understandings between Mr. Gevorgyan and any other person pursuant to which he was selected as an officer. There are no family relationship between Mr. Gevorgyan and any of our officers or directors. Mr. Gevorgyan has not held any other directorships in a company with a class of securities registered pursuant to section 12 of the Exchange Act or subject to the requirements of section 15(d) of such Act or any company registered as an investment company under the Investment Company Act of 1940.

2SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



	NEUROMAMA, LTD.

Date: September 4, 2014	By:	/s/ Igor Weselovsky
		Igor Weselovsky, President, Chief Executive Officer & Director

Filing Compare · NEUROMAMA, LTD.